Shasun Pharmaceuticals successfully completes USFDA inspection at UK facility

14 Nov 2014 Evaluate

Shasun Pharmaceuticals, a global pharmaceutical organization offering world class capabilities and facilities, has successfully completed United States Food and Drug Administration (USFDA) inspection at its manufacturing facility at Dudley England. The USFDA audit was held on first week of November 2014.

On completion of the inspection, the USFDA inspector concluded that the facility, systems and practices comply with USFDA requirements with no observations reported on the form 483.

Shasun Pharmaceuticals manufactures active pharmaceutical ingredients (APIs), their intermediates and enteric coating excipients with a significant presence in some key generics. Shasun has created a strong product portfolio, building on its R&D Expertise, regulatory capabilities and multi scale production capacities. It is one of the largest producers of Ibuprofen worldwide.

Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×